blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1265927

EP1265927 - CRYSTAL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.03.2010
Database last updated on 02.11.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR
published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
Bayer Schering Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
[2007/19]
Former [2007/15]For all designated states
Bayer Schering Pharma AG
Müllerstrasse 178
13353 Berlin / DE
Former [2002/51]For all designated states
SCHERING AKTIENGESELLSCHAFT
13342 Berlin / DE
Inventor(s)01 / DONNER, Peter
Steglitzer Damm 7a
12169 Berlin / DE
02 / EGNER, Ursula
Grainauerstrasse 19
10777 Berlin / DE
03 / CARRONDO, Maria, Armenia
Rua Pero de Alenquer, 95 A
P-2780 469 Paco de Arcos / PT
04 / MATIAS, Pedro, M.
Rua Antonio Rebelo da Silva, 15-1 Dt
P-2780 Porto Salvo / PT
 [2002/51]
Representative(s)Harding, Charles Thomas
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2002/51]Harding, Charles Thomas
D. Young & Co. 21 New Fetter Lane
London EC4A 1DA / GB
Application number, filing date01923873.209.03.2001
[2002/51]
WO2001IB00475
Priority number, dateGB2000000568909.03.2000         Original published format: GB 0005689
[2002/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0166599
Date:13.09.2001
Language:EN
[2001/37]
Type: A1 Application with search report 
No.:EP1265927
Date:18.12.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 13.09.2001 takes the place of the publication of the European patent application.
[2002/51]
Type: B1 Patent specification 
No.:EP1265927
Date:29.04.2009
Language:EN
[2009/18]
Search report(s)International search report - published on:EP13.09.2001
ClassificationIPC:C07K14/72
[2002/51]
CPC:
C07K14/721 (EP,US); A61P35/00 (EP); A61P43/00 (EP);
G01N2500/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/51]
TitleGerman:KRISTALL[2002/51]
English:CRYSTAL[2002/51]
French:CRISTAL[2002/51]
Entry into regional phase26.06.2002National basic fee paid 
26.06.2002Designation fee(s) paid 
26.06.2002Examination fee paid 
Examination procedure05.10.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.06.2002Examination requested  [2002/51]
10.04.2003Despatch of a communication from the examining division (Time limit: M06)
24.11.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
22.01.2004Reply to a communication from the examining division
12.11.2007Cancellation of oral proceeding that was planned for 27.11.2007
12.11.2007Minutes of oral proceedings despatched
27.11.2007Date of oral proceedings (cancelled)
23.07.2008Despatch of a communication from the examining division (Time limit: M04)
14.11.2008Reply to a communication from the examining division
22.12.2008Communication of intention to grant the patent
23.01.2009Fee for grant paid
23.01.2009Fee for publishing/printing paid
Opposition(s)01.02.2010No opposition filed within time limit [2010/14]
Request for further processing for:22.01.2004Request for further processing filed
22.01.2004Full payment received (date of receipt of payment)
Request granted
13.02.2004Decision despatched
Fees paidRenewal fee
26.06.2002Renewal fee patent year 03
17.03.2004Renewal fee patent year 04
15.02.2005Renewal fee patent year 05
13.04.2006Renewal fee patent year 06
15.03.2007Renewal fee patent year 07
20.02.2008Renewal fee patent year 08
31.03.2008Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
31.03.200606   M06   Fee paid on   13.04.2006
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT29.04.2009
CY29.04.2009
DK29.04.2009
FI29.04.2009
TR29.04.2009
GR30.07.2009
PT29.08.2009
[2012/47]
Former [2012/37]AT29.04.2009
CY29.04.2009
DK29.04.2009
FI29.04.2009
GR30.07.2009
PT29.08.2009
Former [2010/47]AT29.04.2009
DK29.04.2009
FI29.04.2009
GR30.07.2009
PT29.08.2009
Former [2010/08]AT29.04.2009
DK29.04.2009
FI29.04.2009
PT29.08.2009
Former [2009/49]AT29.04.2009
FI29.04.2009
PT29.08.2009
Cited inInternational search[X]WO9721993  (UNIV CALIFORNIA [US]) [X] 1-5,7,10,11,13,14,16-18,30,31,34-40 * page 11, line 10 - page 12, line 15; claim 10 *;
 [E]WO0127622  (BRISTOL MYERS SQUIBB CO [US], et al) [E] 1-4,6-11,13-18,30,31,34-40 * the whole document *;
 [DXY]  - WILLIAMS SHAWN P ET AL, "Atomic structure of progesterone complexed with its receptor.", NATURE (LONDON), (19980528), vol. 393, no. 6683, ISSN 0028-0836, pages 392 - 396, XP002173773 [DX] 2,11,36-38,40 * the whole document * [Y] 1-5,7,10,11,34-38,40

DOI:   http://dx.doi.org/10.1038/30775
 [DY]  - YONG E L ET AL, "Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.", MOLECULAR AND CELLULAR ENDOCRINOLOGY, (19980213), vol. 13, no. 1, ISSN 0303-7207, pages 41 - 50, XP001013088 [DY] 1-5,7,10,11,34-38,40 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0303-7207(97)00229-3
 [A]  - GOTTLIEB BRUCE ET AL, "Update of the androgen receptor gene mutations database.", HUMAN MUTATION, (1999), vol. 14, no. 2, ISSN 1059-7794, pages 103 - 114, XP002173777 [A] * the whole document *

DOI:   http://dx.doi.org/10.1002/(SICI)1098-1004(1999)14:2<103::AID-HUMU2>3.0.CO;2-A
 [A]  - ZAVA D T ET AL, "ANDROGEN RECEPTOR ASSAY WITH TRITIATED METHYL TRIENOLONE R-1881 IN THE PRESENCE OF PROGESTERONE RECEPTORS", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1979), Database accession no. PREV197968033984, XP002173787 [A] * abstract *
    [ ] - ENDOCRINOLOGY, EN, (1979), vol. 104, no. 4, ISSN 0013-7227, pages 1007 - 1012
 [PX]  - MATIAS PEDRO M ET AL, "Structural evidence for ligand specificity in the binding domain of the human androgen receptor: Implications for pathogenic gene mutations.", JOURNAL OF BIOLOGICAL CHEMISTRY, (20000825), vol. 275, no. 34, ISSN 0021-9258, pages 26164 - 26171, XP002173776 [PX] 1-4,6-18,30,31,34-40 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.M004571200
 [T]  - KLEBE GERHARD, "Recent developments in structure-based drug design.", JOURNAL OF MOLECULAR MEDICINE (BERLIN), (2000), vol. 78, no. 5, ISSN 0946-2716, pages 269 - 281, XP002173778

DOI:   http://dx.doi.org/10.1007/s001090000084
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.